Vident Investment Advisory, LLC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$447,592
-32.6%
32,887
-3.3%
0.02%
-40.0%
Q4 2022$664,430
+2.4%
34,021
-0.1%
0.02%
+19.0%
Q3 2022$649,000
-16.5%
34,054
-9.7%
0.02%
-8.7%
Q2 2022$777,000
-16.7%
37,702
+30.1%
0.02%
-4.2%
Q1 2022$933,000
-17.1%
28,983
+20.0%
0.02%
-17.2%
Q4 2021$1,125,00024,1530.03%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$88,134,00030.12%
MPM BioImpact LLC 1,745,943$56,184,00015.08%
TANG CAPITAL MANAGEMENT LLC 937,500$30,169,0006.04%
Boxer Capital, LLC 3,192,058$102,720,0005.28%
Octagon Capital Advisors LP 450,776$14,506,0003.14%
RA Capital Management 4,417,259$142,147,0003.10%
SILVERARC CAPITAL MANAGEMENT, LLC 138,843$4,468,0001.85%
BVF INC/IL 1,400,201$45,058,0001.80%
SECTORAL ASSET MANAGEMENT INC 234,150$7,535,0001.34%
Rubric Capital Management LP 822,112$26,456,0000.96%
View complete list of ITEOS THERAPEUTICS INC shareholders